Color filter composition
    1.
    发明授权
    Color filter composition 有权
    彩色滤光片组成

    公开(公告)号:US08319917B1

    公开(公告)日:2012-11-27

    申请号:US13430556

    申请日:2012-03-26

    CPC classification number: G03F7/0007 G02B5/223 G03F7/105

    Abstract: A color filter composition is provided. The color filter composition according to an exemplary embodiment includes a colorant A including a pigment or a dye, a binder resin B, an initiator C, and an assistance colorant D, wherein the initiator absorbs light of an ultraviolet wavelength, and the assistance colorant has a transmittance of more than 60% between about wavelengths 300 nm to 400 nm.

    Abstract translation: 提供了一种滤色器组合物。 根据示例性实施例的滤色器组合物包括着色剂A,其包含颜料或染料,粘合剂树脂B,引发剂C和辅助着色剂D,其中引发剂吸收紫外线波长的光,并且助剂着色剂 在大约波长300nm到400nm之间的透射率大于60%。

    Sustained release drug delivery system composed of water insoluble polymer
    2.
    发明申请
    Sustained release drug delivery system composed of water insoluble polymer 审中-公开
    缓释药物输送系统由水不溶性聚合物组成

    公开(公告)号:US20070275066A1

    公开(公告)日:2007-11-29

    申请号:US11508348

    申请日:2006-08-23

    CPC classification number: A61K9/5078 A61K31/00 A61K31/445 A61K31/517

    Abstract: The present invention relates to a sustained release drug delivery system composed of a water insoluble polymer, and more particularly, to a sustained release drug delivery system comprising: a crystalline core material; an active ingredient layer which is formed on an outer surface of the crystalline core material and comprises a pharmacologically active ingredient and a water insoluble polymer; and a sustained release layer which is formed on an outer surface of the active ingredient layer and comprises a sustained release film forming material. The present invention also relates to a sustained release drug delivery system which releases an effective drug in an aqueous solution or a body fluid for 24 hours by using a sustained release film forming material and a plasticizer together to provide sustained release of a pharmacologically active ingredient.

    Abstract translation: 本发明涉及由不溶于水的聚合物组成的缓释药物递送系统,更具体地说,涉及一种持续释放药物递送系统,包括:结晶芯材料; 活性成分层,其形成在所述结晶核材料的外表面上,并且包含药理活性成分和水不溶性聚合物; 以及持续释放层,其形成在活性成分层的外表面上并且包含缓释膜形成材料。 本发明还涉及一种缓释药物递送系统,其通过使用缓释膜形成材料和增塑剂一起在水溶液或体液中释放有效药物24小时以提供药理活性成分的持续释放。

Patent Agency Ranking